Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Conditions: Inherited Bone Marrow Failure Syndrome; Familial Platelet Disorder With Predisposition to Myeloid Malignancies Interventions: Drug: imatinib; Device: TruSight Oncology Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials

Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes
Condition:   Inherited BMF Syndrome Intervention:   Genetic: The whole-exome sequencing Sponsors:   Sohag University;   Kyoto University;   Assiut University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2022 Category: Research Source Type: clinical trials

The Natural History of Acquired and Inherited Bone Marrow Failure Syndromes.
Conditions:   Severe Aplastic Anemia;   Telomere Biology Disorders;   Inherited Bone Marrow Failure Syndromes Intervention:   Sponsor:   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2021 Category: Research Source Type: clinical trials

Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Conditions:   Severe Aplastic Anemia;   Telomere Biology Disorders;   Inherited Bone Marrow Failure Syndromes Intervention:   Sponsor:   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2021 Category: Research Source Type: clinical trials